Form D · Pharmaceuticals
Phoenix PharmaLabs Inc
Woods Cross, UT · CIK 0001755778
Offering snapshot reported Nov 7, 2018 · SEC filing
- Reported sold
- Yet to sell Offering amount: $3.5M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 7, 2018 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $172K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-325317
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| LIVINGSTON SECURITIES LLC | 147364 | LIVINGSTON SECURITIES LLC · CRD 147364 |
Source: Form D, filed Nov 7, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Timmy Chou | Director, Executive, Promoter |
| William W Crossman | Director, Executive, Promoter |
| John A Lawson | Director, Executive, Promoter |
| Chris Tew | Director, Executive, Promoter |
| Lawrence Toll | Director, Executive, Promoter |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
999 West 1500 South, Building 600
Woods Cross, UT, 84087
Woods Cross, UT, 84087